1. Home
  2. PAMT vs VYGR Comparison

PAMT vs VYGR Comparison

Compare PAMT & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAMT CORP

PAMT

PAMT CORP

N/A

Current Price

$9.93

Market Cap

268.9M

Sector

Industrials

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.75

Market Cap

236.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAMT
VYGR
Founded
1980
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
268.9M
236.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
PAMT
VYGR
Price
$9.93
$3.75
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$13.00
$16.50
AVG Volume (30 Days)
7.1K
557.0K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
$20.12
$34.04
Revenue Next Year
N/A
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.15
$2.65
52 Week High
$17.29
$5.55

Technical Indicators

Market Signals
Indicator
PAMT
VYGR
Relative Strength Index (RSI) 54.99 42.01
Support Level $7.15 $3.72
Resistance Level $10.82 $3.85
Average True Range (ATR) 0.75 0.19
MACD 0.11 -0.02
Stochastic Oscillator 52.02 13.53

Price Performance

Historical Comparison
PAMT
VYGR

About PAMT PAMT CORP

PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: